Akanda AKAN
NASDAQ AKAN
$3.87 -0.19 (-4.67%)
At close: Aug 20, 2026 · 1:57 PM UTC

Akanda (AKAN) Notes Payables (2022 - 2025)

Akanda (AKAN) posted quarterly Notes Payables of $1.0 million for Q4 2025, up 185.4% year-over-year from $352814.0 in Q4 2024, and up 446.39% quarter-over-quarter from $184285.0 in Q2 2025.

Akanda (AKAN) Notes Payables (2022 - 2025) Analysis & Trends

Akanda's Notes Payables history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2025.

  • In Q4 2025, Notes Payables rose 185.4% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 185.4% YoY), while the FY2025 annual figure was $1.0 million, up 185.4% from the prior year.
  • Notes Payables for Q4 2025 stood at $1.0 million, up from $184285.0 in the prior quarter.
  • The five-year high for Notes Payables was $1.0 million in Q4 2025, with the low at $184285.0 in Q2 2025.
  • The 4-year median for Notes Payables is $614801.0 (2023), against an average of $618402.3.
  • The sharpest annual moves came in 2024 and 2025: Notes Payables sank 59.68% in 2024, then jumped 185.4% in 2025.
  • Akanda's Notes Payables stood at $936793.0 in 2022, then fell by 6.59% to $875016.0 in 2023, then tumbled by 59.68% to $352814.0 in 2024, then jumped by 185.4% to $1.0 million in 2025.
  • Business Quant data shows AKAN's Notes Payables at $1.0 million in Q4 2025, $184285.0 in Q2 2025, and $352814.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.91 Bn 42.95 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn -
10 Akanda 267,380.78 267,380.78 -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.01 Mn
Jun 30, 2025 184,285.00
Dec 31, 2024 352,814.00
Jun 30, 2024 354,586.00
Dec 31, 2023 875,016.00
Dec 31, 2022 936,793.00